Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

IDXX
Idexx Laboratories Inc
stock NASDAQ

Market Open
Jun 30, 2026 12:09:33 PM EDT
521.54USD-2.685%(-14.39)206,624
521.00Bid   549.82Ask   28.82Spread
Pre-market
0.00USD-100.000%(-535.93)0
After-hours
Jun 29, 2026 4:00:30 PM EDT
535.93USD-0.003%(-0.02)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 13, 2022
12:09PM EST  One Health Company Collaborates With IDEXX To Expand Access To FidoCure Precision Medicine Platform   Benzinga
11:48AM EST  PetDx, IDEXX Expand Access To OncoK9, A Cancer Liquid Biopsy Test For Dogs   Benzinga
11:44AM EST  IDEXX Enables Improved Cancer Diagnosis And Personalized Care Through Expanded Oncology Offering   Benzinga
09:01AM EST  PetDx and IDEXX Expand Access to OncoK9, the Cancer Liquid Biopsy Test for Dogs   PR Newswire
07:05AM EST  IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency   PR Newswire
07:03AM EST  IDEXX Says Enables Improved Cancer Diagnosis And Personalized Care Through Expanded Oncology Offering   RTTNews
07:00AM EST  IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded   PR Newswire
Jan 11, 2022
03:15PM EST  IDEXX Laboratories to Release 2021 Fourth Quarter and Full Year Financial   PR Newswire
Nov 18, 2021
10:19AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021   Benzinga
08:40AM EST  Morgan Stanley Initiates Coverage On IDEXX Laboratories with Overweight Rating, Announces Price Target of $732   Benzinga
Nov 3, 2021
11:13AM EDT  IDEXX Laboratories shares were trading higher after the company reported better-than-expected Q3 results.   Benzinga
Nov 2, 2021
10:47AM EDT  IDEXX Laboratories Q3 EPS $2.03 Beats $1.91 Estimate, Sales $810.42M Beat $798.16M Estimate   Benzinga
10:47AM EDT  IDEXX Labs Sees FY21 Sales $3.185B-$3.2B vs $3.2B Estimate, EPS $8.30-$8.38 vs $8.38 Est.   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
07:22AM EDT  While announcing higher third -quarter results, IDEXX Laboratories, Inc. (IDXX), a veterinary diagnostics provider, raised its forecast for fiscal 2021, inline or below market estimates. Further, the company tightened revenues outlook.   RTTNews
06:33AM EDT  IDEXX Laboratories Inc (IDXX) released earnings for its third quarter that rose from the same period last year.   RTTNews
06:32AM EDT  IDEXX Labs Reports Q3 Revenue Growth Of 12% Reported And 10% On Organic Basis   RTTNews
06:31AM EDT  IDEXX Laboratories Announces Third Quarter Results   PR Newswire
Oct 8, 2021
04:15PM EDT  IDEXX Laboratories to Release 2021 Third Quarter Financial Results   PR Newswire
Sep 15, 2021
07:10AM EDT  Cramer Weighs In On Lennar, Alibaba And More   Benzinga
Aug 13, 2021
08:00AM EDT  10 Biggest Price Target Changes For Friday   Benzinga
07:01AM EDT  Credit Suisse Maintains Outperform on IDEXX Laboratories, Raises Price Target to $770   Benzinga
Aug 9, 2021
03:30PM EDT  IDEXX Laboratories to Host Virtual Investor Day   PR Newswire
Aug 3, 2021
10:34AM EDT  Goldman Sachs Maintains Neutral on IDEXX Laboratories, Raises Price Target to $610   Benzinga
Aug 2, 2021
08:59AM EDT  Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $750   Benzinga
Jul 30, 2021
07:06AM EDT  IDEXX Laboratories: Q2 Earnings Insights   Benzinga
06:53AM EDT  While announcing higher second-quarter results, IDEXX Laboratories, Inc. (IDXX), a veterinary diagnostics provider, raised its forecast for fiscal 2021 earnings and revenues above market.   RTTNews
06:39AM EDT  IDEXX Laboratories Inc (IDXX) revealed earnings for its second quarter that climbed from last year.   RTTNews
06:37AM EDT  UPDATE: IDEXX Raises FY21 EPS To $8.20-$8.36 vs $8.10 Estimate   Benzinga
06:37AM EDT  IDEXX Laboratories Q2 EPS $2.34 Beats $2.04 Estimate, Sales $826.00M Beat $782.99M Estimate; Raises Guidance   Benzinga
06:32AM EDT  IDEXX Laboratories Q2 EPS $2.34 Vs $1.72 Prior Year   RTTNews
06:31AM EDT  IDEXX Laboratories Announces Second Quarter Results   PR Newswire
04:13AM EDT  Earnings Scheduled For July 30, 2021   Benzinga
Jul 29, 2021
10:44AM EDT  Earnings Outlook For IDEXX Laboratories   Benzinga
Jul 28, 2021
10:45AM EDT  A Look Into IDEXX Laboratories Price Over Earnings   Benzinga
Jul 12, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2021   Benzinga
07:32AM EDT  Guggenheim Downgrades IDEXX Laboratories to Neutral   Benzinga
Jun 30, 2021
04:05PM EDT  IDEXX Laboratories to Release 2021 Second Quarter Financial Results   PR Newswire
Jun 2, 2021
04:29PM EDT  IDEXX Acquires EzyVet   RTTNews
04:26PM EDT  IDEXX Labs Reports Purchase Of ezyVet, No Terms Disclosed   Benzinga
May 26, 2021
11:45AM EDT  IDEXX Laboratories to Present at Stifel Conference and Announces 2021 Virtual   PR Newswire
May 5, 2021
10:11AM EDT  A Look Into IDEXX Laboratories Price Over Earnings   Benzinga
May 4, 2021
07:06AM EDT  IDEXX Laboratories: Q1 Earnings Insights   Benzinga
06:42AM EDT  IDEXX Laboratories Inc (IDXX) revealed a profit for its first quarter that climbed from last year.   RTTNews
06:38AM EDT  IDEXX Laboratories Raises FY21 EPS Guidance To $7.88-$8.18 vs $7.57 Est., Raises Sales Guidance To $3.105B-$3.16B vs $3.09B Est.   Benzinga
06:37AM EDT  IDEXX Laboratories Q1 EPS $2.09 Beats $1.71 Estimate, Sales $777.71M Beat $737.38M Estimate   Benzinga
06:33AM EDT  IDEXX Laboratories Q1 EPS $2.35; Comparable EPS $2.09   RTTNews
06:31AM EDT  IDEXX Laboratories Announces First Quarter Results   PR Newswire
Apr 8, 2021
01:30PM EDT  IDEXX Laboratories to Release 2021 First Quarter Financial Results   PR Newswire
Feb 17, 2021
01:41PM EST  Pet Centric ETF PAWZ First Of Its Kind   Benzinga
10:12AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021   Benzinga
06:50AM EST  Barclays Initiates Coverage On IDEXX Laboratories with Overweight Rating, Announces Price Target of $600   Benzinga
Feb 16, 2021
04:30PM EST  IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences   PR Newswire
Feb 15, 2021
09:36AM EST  Pet Centric ETF PAWZ First Of Its Kind   Benzinga
Feb 2, 2021
07:06AM EST  Recap: IDEXX Laboratories Q4 Earnings   Benzinga
06:56AM EST  UPDATE: IDEXX Laboratories Adj. Q4 EPS $1.76 Beats $1.40 Est.   Benzinga
06:46AM EST  While reporting its financial results for the fourth quarter on Tuesday, IDEXX Laboratories Inc. (IDXX) provided its financial outlook for fiscal 2021 above analysts' expectations.   RTTNews
06:34AM EST  IDEXX Laboratories Sees FY21 EPS $7.39-$7.71 vs $6.81 Est.   Benzinga
06:34AM EST  IDEXX Laboratories Inc (IDXX) revealed earnings for its fourth quarter that climbed from the same period last year.   RTTNews
06:33AM EST  IDEXX Laboratories Q4 EPS $2.01 Beats $1.40 Estimate, Sales $720.94M Beat $681.02M Estimate   Benzinga
06:32AM EST  IDEXX Laboratories Q4 EPS $2.01 Vs $1.04 Last Year   RTTNews
06:31AM EST  IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results   PR Newswire
04:00AM EST  Earnings Scheduled For February 2, 2021   Benzinga
Feb 1, 2021
10:05AM EST  Earnings Preview for IDEXX Laboratories   Benzinga
Jan 29, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021   Benzinga
07:43AM EST  JP Morgan Initiates Coverage On IDEXX Laboratories with Overweight Rating, Announces Price Target of $570   Benzinga
Jan 28, 2021
07:31AM EST  --IDEXX and the Tuskegee University College of Veterinary Medicine Announce   PR Newswire
Jan 11, 2021
02:00PM EST  IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial   PR Newswire
Nov 12, 2020
09:32AM EST  Cramer Shares His Thoughts On CVS Health, T-Mobile, More   Benzinga
07:31AM EST  IDEXX Laboratories Elects Dr. Asha S. Collins to Board of Directors   PR Newswire
Oct 29, 2020
07:48AM EDT  IDEXX Laboratories: Q3 Earnings Insights   Benzinga
06:58AM EDT  IDEXX Laboratories Q3 EPS $1.69 Beats $1.42 Estimate, Sales $721.79M Beat $669.45M Estimate   Benzinga
06:34AM EDT  IDEXX Laboratories Inc (IDXX) announced a profit for its third quarter that climbed from last year.   RTTNews
06:31AM EDT  IDEXX Q3 EPS $1.69, Up 36% On Reported Basis And 47% On Comparable Constant Currency Basis   RTTNews
06:31AM EDT  IDEXX Laboratories Announces Third Quarter Results   PR Newswire
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 5, 2020
04:15PM EDT  IDEXX Laboratories to Release 2020 Third Quarter Financial Results   PR Newswire
Aug 17, 2020
08:40AM EDT  Credit Suisse Maintains Outperform on IDEXX Laboratories, Raises Price Target to $422   Benzinga
Aug 13, 2020
07:32AM EDT  IDEXX Laboratories July U.S. Same-store Clinical Visits Up 6% And U.S. Same-store Total Practice Revenue Up 10%   RTTNews
07:31AM EDT  IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update   PR Newswire
Aug 12, 2020
07:36AM EDT  IDEXX Labs Expands Its Imaging Portfolio To Include ImageVue DR30 Digital Imaging System   RTTNews
07:32AM EDT  safety and superior diagnostic image quality affordable to more veterinarians   PR Newswire
07:32AM EDT  IDEXX Laboratories Announces The Launch Of ProCyte One Hematology Analyzer   RTTNews
07:31AM EDT  IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with   PR Newswire
Aug 10, 2020
07:42AM EDT  IDEXX Laboratories to Host Virtual Investor Day   PR Newswire
Jul 31, 2020
06:43AM EDT  IDEXX Laboratories Inc (IDXX) reported a profit for its second quarter that advanced from the same period last year.   RTTNews
06:39AM EDT  IDEXX Laboratories Q2 EPS $1.72 Beats $1.16 Estimate, Sales $637.59M Beat $589.98M Estimate   Benzinga
06:32AM EDT  IDEXX Laboratories Q2 EPS $1.72 Vs $1.43 Last Year   RTTNews
06:31AM EDT  IDEXX Laboratories Announces Second Quarter Results   PR Newswire
04:15AM EDT  Earnings Scheduled For July 31, 2020   Benzinga
Jul 30, 2020
01:08PM EDT  Stifel Maintains Buy on IDEXX Laboratories, Raises Price Target to $375   Benzinga
Jul 20, 2020
01:00PM EDT  Virtual Investor Day   PR Newswire
11:18AM EDT  B of A Securities Maintains Buy on IDEXX Laboratories, Raises Price Target to $390   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC